Log In
BCIQ
Print this Print this
 

AMO-01 (formerly ECO-4601, TLN-4601)

Also known as: formerly ECO-04601

  Manage Alerts
Collapse Summary General Information
Company Bellus Health Inc.
DescriptionFarnesylated dibenzodiazepinone
Molecular Target Peripheral benzodiazepine receptor (TSPO) (PBR)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationFragile X syndrome
Indication DetailsTreat fragile X syndrome
Regulatory Designation
PartnerAMO Pharma Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today